← Back to all trials
Active Not Recruiting
NCT03968315
An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma
Conditions: Recurrent Malignant Thymoma, Thymoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 40
Sponsor: M.D. Anderson Cancer Center
Location: M D Anderson Cancer Center Houston Texas
Summary
This trial studies the accuracy of a magnetic resonance imaging (MRI) scan in imaging the inside of the chest in patients with thymoma that is newly diagnosed or has come back. An MRI scan may be able to detect if and how far the tumor has spread more accurately than a standard computed tomography (CT) scan.
Eligibility Criteria
Inclusion Criteria:
* All adult patients scheduled to meet with a thoracic surgeon from MD Anderson Cancer Center (ACC) for resection of newly diagnosed thymoma or thymoma recurrence in the chest and scheduled for surgery
Exclusion Criteria:
* Children, defined as individuals younger than 18 years old on the preoperative visit with the thoracic surgeon
* Pregnant patients
* Patients unable to understand the consent form
* Patients with metal within the chest and pacemakers
* Patients with a known allergic reaction to gadolinium, who will have their MRI performed without contrast
* Patients with glomerular filtration rate (GFR) \< 60 ml/min, who will have their MRI performed without contrast
* Patients with an allergy to iodinated contrast material will follow departmental routine policy, that is those with anaphylaxis will have their CT performed without intravenous contrast and others will be prepped as for departmental guidelines for routine chest CT
* Patients with abnormal renal function will have their CT study perform as per DI's iodinated contrast administration guidelines, and no contrast will be administered with GFR lower than 30 ml/min
Source: ClinicalTrials.gov (NCT03968315). StuddyBuddy aggregates publicly available trial information.